Ricerc@Sapienza

Alcoholic liver disease (ALD) is one of the
main indications for liver transplantation (LT) reaching about 30% in
Europe and in the USA. According to the literature 20% > 50% of
patients experience alcohol relapse in the first 5 years after LT. With
this in mind, a program of multidisciplinary support to alcohol
misusers (MSAM) was developed by Our Unit starting from 2004 to
assist patients undergoing LT for ALD. This study aims at analyzing the relapse rate in the group of patients prospectively enrolled for MSAM

Introduction: Alcoholic liver disease (ALD) is one of the main
indications for liver transplantation (LT) reaching about 30% in
Europe and the United States. One of the most important burden in
patients transplanted for ALD is alcohol relapse. In fact, according
to the literature, the 20–50% of patients experience alcohol relapse
in the first 5 years after LT. With this in mind, a program of program
of multidisciplinary support to alcohol misuse (MSAM) was started
up at the Transplant Unit of University of Rome “Sapienza” in 2004